Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Sales | 498 | 1,041 | 150 | 150 | 147 |
| Cost of Goods | -42 | 61 | 37 | 92 | N/A |
| Gross Profit | 540 | 980 | 113 | 58 | 7 |
| Operating Expenses | 2,188 | 2,825 | 2,403 | 2,299 | 2,025 |
| Operating Income | -1,690 | -1,784 | -2,253 | -2,149 | -1,878 |
| Interest Expense | 0 | 237 | 356 | 167 | 163 |
| Other Income | 1,988 | 2,371 | 1,345 | 417 | 4,344 |
| Pre-tax Income | 298 | 350 | -1,264 | -1,899 | 2,303 |
| Net Income Continuous | 281 | 350 | -1,264 | -1,899 | 2,303 |
| Net Income | $281 | $350 | $-1,264 | $-1,899 | $2,303 |
| EPS Basic Total Ops | -12.50 | 0.00 | -112.50 | -150.00 | 125.00 |
| EPS Basic Continuous Ops | 24.04 | 22.43 | -81.49 | -123.36 | 168.35 |
| EPS Diluted Total Ops | -12.50 | 0.00 | -112.50 | -150.00 | 150.00 |
| EPS Diluted Continuous Ops | 24.04 | 22.43 | -81.49 | -123.36 | 248.51 |
| EBITDA(a) | $-1,633 | $-1,728 | $-2,194 | $-2,088 | $-1,819 |